In vitro and in vivo single-agent efficacy of checkpoint kinase inhibition in acute lymphoblastic leukemia.

MLA

Iacobucci, Ilaria, et al. “In Vitro and in Vivo Single-Agent Efficacy of Checkpoint Kinase Inhibition in Acute Lymphoblastic Leukemia.” Journal of Hematology & Oncology, vol. 8, Nov. 2015, pp. 1–15. EBSCOhost, https://doi.org/10.1186/s13045-015-0206-5.

APA

Iacobucci, I., Di Rorà, A. G. L., Verga Falzacappa, M. V., Agostinelli, C., Derenzini, E., Ferrari, A., Papayannidis, C., Lonetti, A., Righi, S., Imbrogno, E., Pomella, S., Venturi, C., Guadagnuolo, V., Cattina, F., Ottaviani, E., Abbenante, M. C., Vitale, A., Elia, L., Russo, D., & Zinzani, P. L. (2015). In vitro and in vivo single-agent efficacy of checkpoint kinase inhibition in acute lymphoblastic leukemia. Journal of Hematology & Oncology, 8, 1–15. https://doi.org/10.1186/s13045-015-0206-5

Chicago

Iacobucci, Ilaria, Andrea Ghelli Luserna Di Rorà, Maria Vittoria Verga Falzacappa, Claudio Agostinelli, Enrico Derenzini, Anna Ferrari, Cristina Papayannidis, et al. 2015. “In Vitro and in Vivo Single-Agent Efficacy of Checkpoint Kinase Inhibition in Acute Lymphoblastic Leukemia.” Journal of Hematology & Oncology 8 (November): 1–15. doi:10.1186/s13045-015-0206-5.